Evidence map›Paper›PMID 25129438›Full record

ArticleVirology2014

Removal of a small C-terminal region of JCV and SV40 large T antigens has differential effects on transformation.

Nicole T M Seneca, Maria Teresa Sáenz Robles, James M Pipas

Abstract read
In one paragraph

Article in Virology, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Nicole T M SenecaDepartment of Biological Sciences, University of Pittsburgh, Pittsburgh, PA 15260, USA.
Maria Teresa Sáenz RoblesDepartment of Biological Sciences, University of Pittsburgh, Pittsburgh, PA 15260, USA.
James M PipasDepartment of Biological Sciences, University of Pittsburgh, Pittsburgh, PA 15260, USA. Electronic address: pipas@pitt.edu.

Funding

Viral Persistence and PathogenesisT32AI049820 · NIAID · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI DELUCA, NEAL A. · 2001 to 2024
$5.5M
Expression of Simian Virus 40 T antigens in IntestineR01CA098956 · NCI · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI PIPAS, JAMES M · 2003 to 2013
$3.2M
Regulation of Transcription and Translation by Human PolyomavirusesR21AI109339 · NIAID · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI PIPAS, JAMES M · 2014 to 2015
$404k
NCI NIH HHS CA98956NCI NIH HHS R01 CA098956NIAID NIH HHS R21 AI109339NIAID NIH HHS T32 AI049820NIAID NIH HHS T32AI049820
6 · The paper itself

Abstract

The large T antigen (LT) protein of JCV and SV40 polyomaviruses is required to induce tumors in rodents and transform cells in culture. When both LTs are compared side-by-side in cell culture assays, SV40 shows a more robust transformation phenotype even though the LT sequences are highly conserved. A complete understanding of SV40׳s enhanced transforming capabilities relative to JCV is lacking. When the least conserved region of the LT proteins, the variable linker and host range region (VHR), was removed, changes in T antigen expression and cellular p53 post-translational modifications occurred, but interaction with the pRB pathway was unaffected. Transformation assessed by growth in low serum was reduced after VHR truncation of the SV40, but not the JCV, T antigen. Conversely, anchorage independent transformation was enhanced only by truncation of the JCV VHR. This is the first report to link the SV40 or JCV VHR region to transformation potential.

Indexed as

AnimalsAntigens, Viral, TumorCells, CulturedCell Transformation, ViralFibroblastsGene Expression Regulation, ViralJC VirusMiceSimian virus 40Antigens, Viral, TumorJCVLarge T antigenPolyomavirusSV40Transformation

Identifiers

PMID25129438
PMCPMC4253650

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.